Trial Profile
A study of humoral and cellular-mediated immune response in Monoclonal gammopathy of Undetermined Significance after vaccination with trivalent inactivated influenza vaccine (influvac)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 08 Jun 2011 New trial record